Business
Bright Green Corporation Merges with PharmAGRI Capital Partners; Lynn Stockwell Appointed CEO and Chairwoman
Tesla Robotics to Power Sovereign “Seed to Syringe” Pharmaceutical Infrastructure Fort Lauderdale, FL, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Bright Green Corporation (OTC: BGXX) has announced its merger with PharmAGRI Capital Partners, a federally aligned pharmaceutical infrastructure platform architected to restore U.S. drug manufacturing sovereignty. The transaction consolidates BGXX’s DEA registrations, Board of Pharmacy licensure, audited financials, and Nasdaq history into PharmAGRI under a co
About this update from Bright Green Corporation
[{"type":"image","alt":"Bright Green Corporation","displaySize":"","headline":null,"caption":"Bright Green Corporation","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":158,"url":"https://media.zenfs.com/en/globenewswire.com/92b43dafdab9975f427194ac2a155729"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/CTdK4O2wZMwX6rvMnaK3Ow--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIyMTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/92b43dafdab9975f427194ac2a155729","width":300,"height":158}},"lazy":false},{"type":"text","content":"Tesla Robotics to Power Sovereign “Seed to Syringe” Pharmaceutical Infrastructure","length":81,"tagName":"p"},{"type":"text","content":"Fort Lauderdale, FL, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Bright Green Corporation (OTC: BGXX) has announced its merger with PharmAGRI Capital Partners, a federally aligned pharmaceutical infrastructure platform architected to restore U.S. drug manufacturing sovereignty. The transaction consolidates BGXX’s DEA registrations, Board of Pharmacy licensure, audited financials, and Nasdaq history into PharmAGRI under a court-supervised restructuring plan filed in the District of New Mexico.","length":488,"tagName":"p"},{"type":"text","content":"Effective immediately, Lynn Stockwell has been appointed Chief Executive Officer and Chairwoman of PharmAGRI. Ms. Stockwell will appoint a new board composed of directors from her Drugs Made In America Acquisition Corps—a series of four Nasdaq-listed special purpose acquisition companies (SPACs) formed to acquire DEA-licensed and FDA-compliant pharmaceutical businesses. Acquisition Corps I has completed an IPO and II is completing the SEC review, with Corps III and IV in formation to expand the platform’s reach and consolidate sovereign production assets.","length":561,"tagName":"p"},{"type":"text","content":"PharmAGRI’s vertically integrated model executes “seed to syringe” drug manufacturing entirely on American soil, supporting EB-5 investor pathways, federal contract capture, and export of U.S.-manufactured controlled substances. As part of the merger, PharmAGRI will assume control of Bright Green LLC, a USCIS- EB-5 Regional Center applicant. The Regional Center will undergo a strategic realignment to support sovereign pharmaceutical infrastructure, robotics deployment, and high-wage job creation consistent with EB-5 program req...